|
| |
| | | 55804 | | 14.12.2001 | | Pfizer AG | | 19.06.2006 | | | | | | | | | | | 07.15. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Rapamune 1 mg | überzogene Tabletten | überzogene Tabletten (Sirolimus 1 mg) | L04AA10 | CI | | 02 | Rapamune 2 mg | überzogene Tabletten | überzogene Tabletten (Sirolimus 2 mg) | L04AA10 | CI | | 03 | Rapamune 0.5 mg | überzogene Tabletten | überzogene Tabletten (Sirolimus 0.5 mg) | L04AA10 | CI |
|
|
|
